Suppression of Theiler's murine encephalomyelitis virus induced demyelinating disease by administration of gangliosides

Journal of Neuroimmunology

Volumn 64, Issue 1, 1996, Pages 45-53

  Inoue, Atsushi ^a   Koh, Chang Sung ^a   Yanagisawa, Nobuo ^a   Taketomi, Tamotsu ^a   Ishihara, Yoshihiro ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Demyelination; Gangliosides; Theiler's murine encephalomyelitis virus

Indexed keywords

CONCANAVALIN A; GANGLIOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030045662     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00149-2     Document Type: Article

References (24)

1. Ballou, L.R. (1992) Sphingolipids and cell function. Immunol. Today 13, 339-341.
2. + T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 73, 1861-1865.
3. Bull Zeller, C. and Marchase, R.B. (1992) Gangliosides as modulators of cell function. Am. J. Physiol. 262 (Cell Physiol. 31), C1341-C1355.
4. Chu, J.W.K. and Sharom, F.J. (1990) Interleukin-2 binds to gangliosides in micelles and lipid bilayers. Biochim. Biophys. Acta 1028, 205-214.
5. Clatch, R.J., Melvold, R.W., Miller, S.D. and Lipton, H.L. (1985) Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135, 1408-1414.
6. Clatch, R.J., Lipton, H.L. and Miller, S.D. (1986) Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136, 920-927.
7. Clatch, R.J., Melvold, R.W., Dal Canto, M.C., Miller, S.D. and Lipton, H.L. (1987) The Theiler's murine encephalomyelitis vims (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B and C. J. Neuroimmunol. 15, 121-135.
8. Crane, M.A., Jue, C., Mitchell, M., Lipton, H.L. and Kim, B.S. (1990) Detection of restricted predominant epitopes of Theiler's murine encephalomyelitis virus capsid proteins expressed in the λgt11 system: different patterns of antibody reactivity among different mouse strains. J. Neuroimmunol. 27, 173-186.
9. Friedmann, A., Frankel, G., Lorch, Y. and Steinman, L. (1987) Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment. J. Virol. 61, 898-903.
10. Frugoni, P., Secchi, E.F. and Chizzolini, C. (1994) Effects of pure bovine brain-derived gangliosides on normal human B cell proliferation in vitro. J. Neuroimmunol. 49, 189-195.
11. Gerety, S.J., Karpus, W.J., Cubbon, A.R., Goswami, R.G., Rundell, M.K., Peterson, J.D. and Miller, S.D. (1994a) Class H-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathological VP2 T cell epitope in susceptible SJL/J mice. J. Immunol. 152, 908-918.
12. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152, 919-929.
13. Grassi, F., Lopalco, L., Ciccomascolo, F., Cazzola, F., Di Martino, A., Kirschner, G., Callegaro, L., Chieco-Bianchi, L. and Siccardi, A.G. (1990) Chemical residues of ganglioside molecule involved in interactions with lymphocyte surface targets leading to CD4 masking and inhibition of mitogenic proliferation. Eur. J. Immunol. 20, 145-150.
14. Hakomori, S. (1990) Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem. 265, 18713-18716.
15. Hannun, Y.A. and Bell, R.M. (1989) Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243, 500-507.
16. Inoue, A., Choe, Y.-K. and Kim, B.S. (1994) Analysis of antibody response to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J. Virol. 68, 3324-3333.
17. Kappel, C.A., Dal Canto, M.C., Melvold, R.W. and Kim, B.S. (1991) Hierarchy of effects of the MHC and T cell receptor β-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 147, 4322-4326.
18. Karpiak, S.E., Li, Y.S. and Mahadik, S.P. (1987) Gangliosides treatment: reduction of CNS injury and facilitation of functional recovery. Brain Injury 1, 161-170.
19. Kastner, A., Herrero, M.T., Hirsch, E.C., Guillen, J., Luquin, M.R., Javoy-Agid, F., Obeso, J.A. and Agid, Y. (1994) Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of Levodopa and GM1 ganglioside therapy. Ann. Neurol. 36, 206-214.
20. Ledeen, R.W. (1984) Biology of gangliosides: Neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12, 147-159.
21. Ledeen, R.W., Oderfeld-Nowak, B., Brosnan, C.F. and Cervone, A. (1990) Gangliosides offer partial protection in experimental allergic neuritis. Ann. Neurol. 27 (Suppl.), S69-S74.
22. Lehrich, J.R., Arnason, B.G.W. and Hochberg, F. (1976) Demyelinative myelopathy in mice induced by the DA virus. J. Neurol. Sci. 29, 149-160.
23. Lipton, H.L. (1975) Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11, 1147-1155.
24. Lipton, H.L. and Dal Canto, M.C. (1976a) Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 30, 201-207.